Effects of Reduced Dietary Sodium and the DASH Diet on Glomerular Filtration Rate: The DASH-Sodium Trial.


Journal

Kidney360
ISSN: 2641-7650
Titre abrégé: Kidney360
Pays: United States
ID NLM: 101766381

Informations de publication

Date de publication:
08 Feb 2024
Historique:
received: 06 12 2023
accepted: 01 02 2024
medline: 8 2 2024
pubmed: 8 2 2024
entrez: 8 2 2024
Statut: aheadofprint

Résumé

A potassium-rich DASH diet combined with low sodium reduces blood pressure. However, the effects of sodium reduction in combination with the DASH diet on kidney function are unknown. We aimed to determine the effects of sodium reduction and the DASH diet, on estimated glomerular filtration rate (eGFR) by cystatin C. DASH-Sodium was a controlled, feeding study in adults with elevated or stage 1 hypertension, randomly assigned to the DASH or a control diet. On their assigned diet, participants consumed each of three sodium levels for 30 days following a 2-week run-in period of a high sodium-control diet. The three sodium levels were low (50 mmol/d), medium (100 mmol/d), and high (150 mmol/d). The primary outcome was change in eGFR based on cystatin C. Cystatin C was measured in 409 of the original 412 participants of which 207 were assigned the DASH diet and 202 to the control diet. Compared with control, the DASH diet did not affect eGFR (β=-0.96 mL/min/1.73 m2; 95%CI: -2.74, 0.83). In contrast, low versus high sodium intake decreased eGFR (β=-2.36 mL/min/1.73 m2; 95%CI: -3.64, -1.07). Together, compared to the high sodium-control diet, the low sodium-DASH diet decreased eGFR by 3.10 mL/min/1.73 m2 (95%CI: -5.46, -0.73). This effect was attenuated with adjustment for diastolic blood pressure and 24-hr urinary potassium excretion. A combined low sodium-DASH diet reduced eGFR over a 4-week period. Future research should focus on the impact of these dietary interventions on subclinical kidney injury and their long-term impact on progression to chronic kidney disease.

Identifiants

pubmed: 38326949
doi: 10.34067/KID.0000000000000390
pii: 02200512-990000000-00341
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK03836
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK03836
Pays : United States

Informations de copyright

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology.

Auteurs

Martha Catalina Morales-Alvarez (MC)

Department of Nephrology. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston Massachusetts.

Voravech Nissaisorakarn (V)

Department of Nephrology. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston Massachusetts.

Lawrence J Appel (LJ)

The Johns Hopkins University School of Medicine, The Johns Hopkins Bloomberg School of Public Health, and The Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland.

Edgar R Miller (ER)

The Johns Hopkins University School of Medicine, The Johns Hopkins Bloomberg School of Public Health, and The Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland.

Robert Christenson (R)

Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Heather Rebuck (H)

Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Sylvia E Rosas (SE)

Department of Nephrology. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston Massachusetts.
Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.

Jeffrey H William (JH)

Department of Nephrology. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston Massachusetts.

Stephen P Juraschek (SP)

Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Classifications MeSH